Ovarian Endometrioid Adenocarcinoma Active Not Recruiting Phase 3 Trials for Docetaxel (DB01248)
Indication | Status | Phase |
---|---|---|
DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma) | Active Not Recruiting | 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00565851 | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | Treatment |